Your browser doesn't support javascript.
loading
Nanoparticle-enhanced proton beam immunoradiotherapy drives immune activation and durable tumor rejection.
Hu, Yun; Paris, Sébastien; Sahoo, Narayan; Bertolet, Genevieve; Wang, Qi; Wang, Qianxia; Barsoumian, Hampartsoum B; Da Silva, Jordan; Huang, Ailing; Doss, Denaha J; Pollock, David P; Hsu, Ethan; Selene, Nanez; Leyton, Claudia S Kettlun; Voss, Tiffany A; Masrorpour, Fatemeh; Ganjoo, Shonik; Leuschner, Carola; Pietz, Jordan T; Puebla-Osorio, Nahum; Gandhi, Saumil; Nguyen, Quynh-Nhu; Wang, Jing; Cortez, Maria Angelica; Welsh, James W.
Afiliação
  • Hu Y; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Paris S; Department of Translational Science, Nanobiotix, Paris, France.
  • Sahoo N; Department of Radiation Physics, and.
  • Bertolet G; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wang Q; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wang Q; Department of Radiation Physics, and.
  • Barsoumian HB; Department of Physics and Astronomy, Rice University, Houston, Texas, USA.
  • Da Silva J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Huang A; Department of Translational Science, Nanobiotix, Paris, France.
  • Doss DJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Pollock DP; Department of Genetics, and.
  • Hsu E; Department of Genetics, and.
  • Selene N; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Leyton CSK; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Voss TA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Masrorpour F; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ganjoo S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Leuschner C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Pietz JT; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Puebla-Osorio N; Department of Strategic Communication, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Gandhi S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Nguyen QN; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wang J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Cortez MA; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Welsh JW; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
JCI Insight ; 8(12)2023 06 22.
Article em En | MEDLINE | ID: mdl-37345658
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanopartículas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: JCI Insight Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanopartículas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: JCI Insight Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos